InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by ADAMS ADRIAN, Director. Insider active across 3 companies, notably Akebia Therapeutics, Inc.. Aggregated, 7 filings have been recorded. Total volume traded: €406k. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
013,700 shares0
Common Stock
SEC:0001562180-22-004973:0·
€202,94017,203 shares@ €11.7968100.0% of flow
Common Stock
SEC:0001209191-21-052595·
Ideal exit: 15 May 2022 (T+270)
€202,94017,203 shares@ €11.796850.0% of flow
Common Stock
SEC:0001209191-21-052595:0·
Ideal exit: 15 May 2022 (T+270)
010,000 shares0
Common Stock
SEC:0001209191-21-041579·
010,000 shares0
Common Stock
SEC:0001209191-21-041579:0·
013,700 shares0
Common Stock
SEC:0001562180-21-004026·
013,700 shares0
Common Stock
SEC:0001562180-21-004026:0·
7 of 7 declarations
About ADAMS ADRIAN
Adrian Adams serves as Director, Chairman, CEO, and President at Akebia Therapeutics, Inc., ACELRX Pharmaceuticals Inc., and Impel Neuropharma Inc. He is responsible for the strategic and operational leadership of these companies, ensuring their growth and development. Adams brings extensive experience in the biopharmaceutical sector, contributing to innovation and improving patient outcomes.
